Back-Half EPS Guidance of $3 per Share
Company is guiding to ~$3.00 in EPS for the back half of FY2026, assuming supply chains begin to unwind by the end of Q2; management emphasizes focus on cash generation and positioning for resilience.
Acetyl Chain Q2 Improvement (~$200M Lift)
Management indicated the acetyl chain should deliver materially stronger results in Q2 versus Q1 (discussion referenced ~<$200M incremental improvement), with the majority of near-term profit weighted to the Western Hemisphere and profitability driven more by downstream products (VAM, vinyl emulsions, redispersible powders) than selling acetic acid alone.
Engineered Materials EBITDA Margin Expansion (>20%)
Company reports progress in Engineered Materials (EM) margin profile — having moved from 'low‑teens' EBITDA margins historically to 'consistently north of 20%'; management expects EM to grow year-over-year (ex-Micromax) and to continue fortifying the business through cost and complexity reductions.
Nylon Optimization Program Targeting $30M of Savings
New strategic initiatives in Nylon expected to generate ~$30 million of annual cost savings; ~1/3 of savings (≈$10M) expected to start in the second half of the year, with an incremental cash cost to achieve the program that implies a payback of less than one year and has been included in free cash flow forecasts.
Clear Lake and Network Flexibility — High Utilization
Clear Lake asset running at relatively high utilization and provides a low‑cost, flexible advantage; management highlights ability to operate global units (e.g., Frankfurt, Singapore) as 'swing' assets and to pivot operating rates across the acetyl and EM chains to capture demand changes.
Pricing Actions and Expected Flow-Through into P&L
EM price increases are beginning to flow in Q2 with the expectation that cost pass-through and pricing will more fully impact the P&L in Q3; management notes they are actively securing volumes and contract business to lock in upside.
Free Cash Flow and Working Capital Plan
At the midpoint of guidance, a multi‑hundred million dollar increase in EBITDA is expected to translate into free cash flow, with management assuming roughly half of the incremental EBITDA converts to cash in 2026 and half in 2027; company continues inventory-reduction efforts in EM and had previously expected a ~$100M working capital tailwind but now sees working capital closer to flat for the year.